Immunisation policies--successes, failures and the future.
作者信息
Miller E
机构信息
Immunisation Division, PHLS Communicable Disease Surveillance Centre, London.
出版信息
J Clin Pathol. 1996 Aug;49(8):620-2. doi: 10.1136/jcp.49.8.620.
Abstract
摘要
相似文献
1
Immunisation policies--successes, failures and the future.
J Clin Pathol. 1996 Aug;49(8):620-2. doi: 10.1136/jcp.49.8.620.
2
Strengthening vaccination policies in Latin America: an evidence-based approach.
Vaccine. 2013 Aug 20;31(37):3826-33. doi: 10.1016/j.vaccine.2012.12.062. Epub 2013 Jan 25.
3
Paving the way for the introduction of new vaccines into developing countries.
Expert Rev Vaccines. 2005 Apr;4(2):147-50. doi: 10.1586/14760584.4.2.147.
4
Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Vaccine. 2005 Aug 31;23(37):4610-8. doi: 10.1016/j.vaccine.2005.04.044.
5
WHO report paints mixed picture of immunisation progress.
Lancet. 2002 Nov 23;360(9346):1671. doi: 10.1016/S0140-6736(02)11661-8.
6
Advances in the control of vaccine preventable diseases in Ethiopia.
Pan Afr Med J. 2017 Jun 9;27(Suppl 2):1. doi: 10.11604/pamj.supp.2017.27.2.12701. eCollection 2017.
7
Global progress towards universal childhood hepatitis B vaccination, 2003.
Wkly Epidemiol Rec. 2003 Oct 17;78(42):366-70.
8
Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
Vaccine. 2008 Dec 2;26(51):6529-41. doi: 10.1016/j.vaccine.2008.08.067.
9
The switch to new conjugated vaccines may compromise immunisation coverage for refugees.
Med J Aust. 2006 May 1;184(9):473. doi: 10.5694/j.1326-5377.2006.tb00324.x.
10
Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
Vaccine. 2013 Apr 8;31(15):1886-91. doi: 10.1016/j.vaccine.2013.02.024. Epub 2013 Feb 24.
引用本文的文献
1
Nanotechnology in vaccine delivery.
Adv Drug Deliv Rev. 2008 May 22;60(8):915-28. doi: 10.1016/j.addr.2007.05.017. Epub 2008 Feb 7.
本文引用的文献
1
MEASLES IMMUNIZATION WITH KILLED VIRUS VACCINE. SERUM ANTIBODY TITERS AND EXPERIENCE WITH EXPOSURE TO MEASLES EPIDEMIC.
Am J Dis Child. 1965 Mar;109:232-7. doi: 10.1001/archpedi.1965.02090020234007.
2
Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination.
J Infect Dis. 1996 Jan;173(1):32-7. doi: 10.1093/infdis/173.1.32.
3
Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate.
J Pediatr. 1993 Jun;122(6):904-8. doi: 10.1016/s0022-3476(09)90015-4.
4
Potential of polymer microencapsulation technology for vaccine innovation.
Vaccine. 1994 Jan;12(1):5-11. doi: 10.1016/0264-410x(94)90003-5.
5
Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3.
BMJ. 1994 Apr 16;308(6935):1015-7. doi: 10.1136/bmj.308.6935.1015.
6
Russian contribution to OPV.
Biologicals. 1993 Dec;21(4):321-5. doi: 10.1006/biol.1993.1091.
7
Invasive Haemophilus influenzae disease: the impact of Hib immunisation.
J Med Microbiol. 1995 Feb;42(2):75-7. doi: 10.1099/00222615-42-2-75.
8
Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy.
Epidemiol Infect. 1995 Aug;115(1):139-56. doi: 10.1017/s0950268800058209.
9
Vaccine technologies: view to the future.
Science. 1994 Sep 2;265(5177):1401-4. doi: 10.1126/science.7521064.
10
Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world.
J Infect Dis. 1985 Mar;151(3):420-36. doi: 10.1093/infdis/151.3.420.
Zotero 插件